ArticleJournal of atherosclerosis and thrombosis2019

Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment.

Hiroyasu Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.